Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01693276
What this trial is testing

Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Olugbenga Olowokure 3
Not applicableLooking for participantsNCT06028724
What this trial is testing

A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)

Who this might be right for
Solid TumorAdvanced Solid TumorLocally Advanced Solid Tumor+11 more
Centro di Riferimento Oncologico - Aviano 782
Not applicableUnknownNCT06206382
What this trial is testing

Surgical Results of Resection of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Assiut University 80
Not applicableEnded earlyNCT03531125
What this trial is testing

Gene Expression in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Oxford 9
Not applicableEnded earlyNCT02926040
What this trial is testing

Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Insel Gruppe AG, University Hospital Bern 14
Not applicableStudy completedNCT01278368
What this trial is testing

Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Università Vita-Salute San Raffaele 150
Testing effectiveness (Phase 2)Study completedNCT00383760
What this trial is testing

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more
National Cancer Institute (NCI) 15
Not applicableUnknownNCT03690323
What this trial is testing

Pancreatic Locally Advanced Irresectable Cancer Ablation

Who this might be right for
Locally Advanced Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 228
Early research (Phase 1)Looking for participantsNCT06278454
What this trial is testing

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

Who this might be right for
Unresectable Pancreatic CancerAdvanced Pancreatic CancerLymph Node Metastases
Chengdu New Radiomedicine Technology Co. LTD. 58
Very early researchStudy completedNCT01715142
What this trial is testing

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma ResectablePancreatic Adenocarcinoma Locally AdvancedPancreatic Adenocarcinoma Metastatic
Jean-Luc Van Laethem 23
Testing effectiveness (Phase 2)Ended earlyNCT03585062
What this trial is testing

Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer

Who this might be right for
Pancreatic CancerNeoadjuvant Chemotherapy
Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Looking for participantsNCT07645651
What this trial is testing

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
University of Washington 15
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)UnknownNCT02439593
What this trial is testing

Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study

Who this might be right for
Cancer Pancreas
Kantonsspital Aarau 78
Not applicableNot Yet RecruitingNCT07325214
What this trial is testing

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic CancerLocally Advanced Pancreatic Cancer
IMGT Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT04156087
What this trial is testing

Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Baki Topal 12
Early research (Phase 1)Not Yet RecruitingNCT07555587
What this trial is testing

Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

Who this might be right for
Unresectable Locally Advanced Pancreatic Carcinoma
NRT MedTech Australia Pty Ltd 10
Testing effectiveness (Phase 2)Ended earlyNCT04983407
What this trial is testing

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Aravive, Inc. 34
Next Page